Evidence map›Paper›PMID 36409468›Full record

ArticleJMIR medical informatics2022

State-of-the-Art Evidence Retriever for Precision Medicine: Algorithm Development and Validation.

Qiao Jin, Chuanqi Tan, Mosha Chen, Ming Yan, Ningyu Zhang, Songfang Huang, Xiaozhong Liu

Abstract read
In one paragraph

Article in JMIR medical informatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Qiao JinAlibaba Group, Hangzhou, China.ORCID https://orcid.org/0000-0002-1268-7239
Chuanqi TanAlibaba Group, Hangzhou, China.ORCID https://orcid.org/0000-0002-6676-3057
Mosha ChenAlibaba Group, Hangzhou, China.ORCID https://orcid.org/0000-0001-8815-6031
Ming YanAlibaba Group, Hangzhou, China.ORCID https://orcid.org/0000-0003-4959-8878
Ningyu ZhangZhejiang University, Zhejiang, China.ORCID https://orcid.org/0000-0002-1970-0678
Songfang HuangAlibaba Group, Hangzhou, China.ORCID https://orcid.org/0000-0001-8084-0904
Xiaozhong LiuIndiana University Bloomington, Bloomington, IN, United States.ORCID https://orcid.org/0000-0003-3477-8323

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUnder the paradigm of precision medicine (PM), patients with the same disease can receive different personalized therapies according to their clinical and genetic features. These therapies are determined by the totality of all available clinical evidence, including results from case reports, clinical trials, and systematic reviews. However, it is increasingly difficult for physicians to find such evidence from scientific publications, whose size is growing at an unprecedented pace.

objectiveIn this work, we propose the PM-Search system to facilitate the retrieval of clinical literature that contains critical evidence for or against giving specific therapies to certain cancer patients.

methodsThe PM-Search system combines a baseline retriever that selects document candidates at a large scale and an evidence reranker that finely reorders the candidates based on their evidence quality. The baseline retriever uses query expansion and keyword matching with the ElasticSearch retrieval engine, and the evidence reranker fits pretrained language models to expert annotations that are derived from an active learning strategy.

resultsThe PM-Search system achieved the best performance in the retrieval of high-quality clinical evidence at the Text Retrieval Conference PM Track 2020, outperforming the second-ranking systems by large margins (0.4780 vs 0.4238 for standard normalized discounted cumulative gain at rank 30 and 0.4519 vs 0.4193 for exponential normalized discounted cumulative gain at rank 30).

conclusionsWe present PM-Search, a state-of-the-art search engine to assist the practicing of evidence-based PM. PM-Search uses a novel Bidirectional Encoder Representations from Transformers for Biomedical Text Mining-based active learning strategy that models evidence quality and improves the model performance. Our analyses show that evidence quality is a distinct aspect from general relevance, and specific modeling of evidence quality beyond general relevance is required for a PM search engine.

Indexed as

active learningalgorithm developmentbig datadata retrievaldigital health interventionevidence-based medicineinformation retrievalprecision medicinepretrained language models

Identifiers

PMID36409468
PMCPMC9801267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.